A Study of Ramantamig Plus Daratumumab Versus Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone (DVRd) or Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With NDMM For Whom Stem Cell Transplant is Not Planned
Clinical trial NCT07665450 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07665450
- Sponsor
- Janssen Research & Development, LLC
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-14
- Primary completion
- 2030-09-04
- Enrollment
- 1000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.